These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32549544)

  • 21. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
    Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
    Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
    J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.
    Huppler AR; Bishu S; Gaffen SL
    Arthritis Res Ther; 2012 Jul; 14(4):217. PubMed ID: 22838497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
    Nielsen J; Kofod-Olsen E; Spaun E; Larsen CS; Christiansen M; Mogensen TH
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case Report: Disseminated
    Chen K; Tan J; Qian S; Wu S; Chen Q
    Front Immunol; 2021; 12():682350. PubMed ID: 34421897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
    J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
    Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
    Front Immunol; 2018; 9():2570. PubMed ID: 30510552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
    J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
    Puel A; Cypowyj S; Bustamante J; Wright JF; Liu L; Lim HK; Migaud M; Israel L; Chrabieh M; Audry M; Gumbleton M; Toulon A; Bodemer C; El-Baghdadi J; Whitters M; Paradis T; Brooks J; Collins M; Wolfman NM; Al-Muhsen S; Galicchio M; Abel L; Picard C; Casanova JL
    Science; 2011 Apr; 332(6025):65-8. PubMed ID: 21350122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
    Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
    Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
    Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
    J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.
    Mekki N; Ben-Mustapha I; Liu L; Boussofara L; Okada S; Cypowyj S; Ghariani N; Saidi W; Denguezli M; Casanova JL; Puel A; Barbouche MR
    J Invest Dermatol; 2014 Apr; 134(4):1155-1157. PubMed ID: 24335902
    [No Abstract]   [Full Text] [Related]  

  • 35. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
    Kisand K; Lilic D; Casanova JL; Peterson P; Meager A; Willcox N
    Eur J Immunol; 2011 Jun; 41(6):1517-27. PubMed ID: 21574164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.
    Andou M; Tominaga M; Nishikomori R; Gotoh K; Komatsu N; Matsuoka M; Kawayama T; Hoshino T
    Intern Med; 2024 May; 63(9):1269-1271. PubMed ID: 37779067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.
    Fabbri M; Frixou M; Degano M; Fousteri G
    Diabetes; 2019 Feb; 68(2):258-265. PubMed ID: 30665954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T
    Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
    Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
    Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Th17/IL-17 Axis and Host Defense Against Fungal Infections.
    Tangye SG; Puel A
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1624-1634. PubMed ID: 37116791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.